Healthcare

FNArena Windows (Sectors)

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

Latest Stories

It has become the 'unofficial' tradition in recent years: an interview with Livewire Markets ahead of yet another corporate reporting…

Feb 19 2024

Artificial intelligence and some valuable experiences should benefit heart device developer Artrya, Tim Boreham explains

Feb 15 2024


ASX CODE COMPANY NAME LAST PRICE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET
4DX 4DMEDICAL LIMITED $0.64 $1.27 $0.29

$1.225

ACL AUSTRALIAN CLINICAL LABS LIMITED $2.77 $3.87 $2.47 15.4

$3.367

ALC ALCIDION GROUP LIMITED $0.05 $0.14 $0.05

$0.08

APM APM HUMAN SERVICES INTERNATIONAL LIMITED $1.33 $2.44 $0.68 11.7

$1.598

ARX AROA BIOSURGERY LIMITED $0.58 $1.12 $0.54

$1.05

AVH AVITA MEDICAL INC $4.78 $xx.xx $xx.xx xx.x xx.xx
BMT BEAMTREE HOLDINGS LIMITED $0.22 $xx.xx $xx.xx xx.x xx.xx
CAJ CAPITOL HEALTH LIMITED $0.26 $xx.xx $xx.xx xx.x xx.xx
CAT CATAPULT GROUP INTERNATIONAL LIMITED $1.28 $xx.xx $xx.xx xx.x xx.xx
CGS COGSTATE LIMITED $1.21 $xx.xx $xx.xx xx.x xx.xx
COH COCHLEAR LIMITED $343.73 $xx.xx $xx.xx xx.x xx.xx
CSL CSL LIMITED $285.34 $xx.xx $xx.xx xx.x xx.xx
CU6 CSL LIMITED $2.58 $xx.xx $xx.xx xx.x xx.xx
CUV CLINUVEL PHARMACEUTICALS LIMITED $14.32 $xx.xx $xx.xx xx.x xx.xx
CYC CYCLOPHARM LIMITED $1.85 $xx.xx $xx.xx xx.x xx.xx
EBO EBOS GROUP LIMITED $34.00 $xx.xx $xx.xx xx.x xx.xx
EBR EBR SYSTEMS INC $0.75 $xx.xx $xx.xx xx.x xx.xx
FPH FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED $23.21 $xx.xx $xx.xx xx.x xx.xx
GSS GENETIC SIGNATURES LIMITED $0.51 $xx.xx $xx.xx xx.x xx.xx
HLS HEALIUS LIMITED $1.37 $xx.xx $xx.xx xx.x xx.xx
IDX INTEGRAL DIAGNOSTICS LIMITED $2.27 $xx.xx $xx.xx xx.x xx.xx
IME IMEXHS LIMITED $0.65 $xx.xx $xx.xx xx.x xx.xx
IMM IMMUTEP LIMITED $0.35 $xx.xx $xx.xx xx.x xx.xx
IMU IMMUTEP LIMITED $0.12 $xx.xx $xx.xx xx.x xx.xx
INA INGENIA COMMUNITIES GROUP $4.88 $xx.xx $xx.xx xx.x xx.xx
IPD IMPEDIMED LIMITED $0.09 $xx.xx $xx.xx xx.x xx.xx
LIC LIFESTYLE COMMUNITIES LIMITED $15.08 $xx.xx $xx.xx xx.x xx.xx
M7T MACH7 TECHNOLOGIES LIMITED $0.72 $xx.xx $xx.xx xx.x xx.xx
MAP MICROBA LIFE SCIENCES LIMITED $0.18 $xx.xx $xx.xx xx.x xx.xx
MDR MEDADVISOR LIMITED $0.29 $xx.xx $xx.xx xx.x xx.xx
MPL MEDIBANK PRIVATE LIMITED $3.63 $xx.xx $xx.xx xx.x xx.xx
MSB MESOBLAST LIMITED $0.29 $xx.xx $xx.xx xx.x xx.xx
MVF MONASH IVF GROUP LIMITED $1.43 $xx.xx $xx.xx xx.x xx.xx
MVP MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED $0.92 $xx.xx $xx.xx xx.x xx.xx
MX1 MICRO-X LIMITED $0.12 $xx.xx $xx.xx xx.x xx.xx
NAN NANOSONICS LIMITED $3.13 $xx.xx $xx.xx xx.x xx.xx
NEU NEUREN PHARMACEUTICALS LIMITED $20.75 $xx.xx $xx.xx xx.x xx.xx
NHF NIB HOLDINGS LIMITED $8.18 $xx.xx $xx.xx xx.x xx.xx
PAR PARADIGM BIOPHARMACEUTICALS LIMITED $0.36 $xx.xx $xx.xx xx.x xx.xx
PBP PROBIOTEC LIMITED $2.79 $xx.xx $xx.xx xx.x xx.xx
PER PERCHERON THERAPEUTICS LIMITED $0.07 $xx.xx $xx.xx xx.x xx.xx
PGC PARAGON CARE LIMITED $0.21 $xx.xx $xx.xx xx.x xx.xx
PME PRO MEDICUS LIMITED $98.22 $xx.xx $xx.xx xx.x xx.xx
PNV POLYNOVO LIMITED $1.99 $xx.xx $xx.xx xx.x xx.xx
PSQ PACIFIC SMILES GROUP LIMITED $1.40 $xx.xx $xx.xx xx.x xx.xx
REG REGIS HEALTHCARE LIMITED $3.41 $xx.xx $xx.xx xx.x xx.xx
RHC RAMSAY HEALTH CARE LIMITED $50.75 $xx.xx $xx.xx xx.x xx.xx
RMD RESMED INC $27.99 $xx.xx $xx.xx xx.x xx.xx
SHL SONIC HEALTHCARE LIMITED $29.30 $xx.xx $xx.xx xx.x xx.xx
TLX TELIX PHARMACEUTICALS LIMITED $10.52 $xx.xx $xx.xx xx.x xx.xx
TRJ TRAJAN GROUP HOLDINGS LIMITED $1.22 $xx.xx $xx.xx xx.x xx.xx
VHT VOLPARA HEALTH TECHNOLOGIES LIMITED $1.12 $xx.xx $xx.xx xx.x xx.xx
VIT VITURA HEALTH LIMITED $0.23 $xx.xx $xx.xx xx.x xx.xx
Previous Stories
Spotlight On ASX-Listed Cannabis Companies

Jan 31 2024

Some cannabis gems are sprouting in the ASX weed patch, but they are hard to find in the haze of hype, Tim Boreham, Editor, The New Criterion reports


ResMed Recovery Turns Into Hollywood Script

Jan 31 2024

More troubles for key competitor Philips/Respironics suggests there could be more momentum shifting in ResMed’s favour


ResMed Makes A Comeback

Jan 29 2024

ResMed’s December quarter showed long-awaited margin improvement and relieved market fears of the impact of weight-loss drugs


Rudi’s View: Healthcare, REITs, Uranium & Banks

Jan 24 2024

Notes from expert views and strategy updates regarding the local share market in early 2024


ResMed: The Recovery Has Begun

Jan 23 2024

Michael Gable of Fairmont Equities observes market dynamics for ResMed have changed for the better with price action suggesting higher prices are on the cards


Transformational Trial Results For Neuren Pharmaceuticals

Dec 20 2023

Brokers raise valuations for Neuren Pharmaceuticals following positive Phase 2 clinical trial results


Dr Boreham’s Crucible: Imugene

Dec 11 2023

Tim Boreham highlights the prospects for cancer treatment biotech Imugene


Dr Boreham’s Crucible: PYC Therapeutics

Nov 22 2023

Tim Boreham highlights how PYC Therapeutics’ gene therapy can address a plethora of genetic afflictions


Dr Boreham’s Crucible: Paradigm Biopharmaceuticals

Nov 06 2023

Tim Boreham highlights the success of Paradigm Biopharmaceuticals’ joint pain drug ahead of a capital raising


Treasure Chest: Ramsay Health Care

Oct 26 2023

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is on Ramsay Health Care